Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers. McAdam BF, Byrne D, Morrow JD, Oates JA (2005) Circulation 112: 1024-9 Relative importance of thrombin compared with plasmin-mediated platelet activation in response to plasminogen activation with streptokinase. Winters KJ, Santoro SA, Miletich JP, Eisenberg PR (1991) Circulation 84: 1552-60 Vascular responses to leukocyte products in atherosclerotic primates. Lopez JA, Armstrong ML, Harrison DG, Piegors DJ, Heistad DD (1989) Circ Res 65: 1078-86 New risk factors for adult-onset incident asthma. A nested case-control study of host antioxidant defense. Larkin EK, Gao YT, Gebretsadik T, Hartman TJ, Wu P, Wen W, Yang G, Bai C, Jin M, Roberts LJ, Gross M, Shu XO, Hartert TV (2015) Am J Respir Crit Care Med 191: 45-53 Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential. Gailani D, Ho D, Sun MF, Cheng Q, Walsh PN (2001) Blood 97: 3117-22 Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Tucker EI, Marzec UM, White TC, Hurst S, Rugonyi S, McCarty OJ, Gailani D, Gruber A, Hanson SR (2009) Blood 113: 936-44 Effects of Acute and Antecedent Hypoglycemia on Endothelial Function and Markers of Atherothrombotic Balance in Healthy Humans. Joy NG, Tate DB, Younk LM, Davis SN (2015) Diabetes 64: 2571-80 Platelet activation leads to increased c-src kinase activity and association of c-src with an 85-kDa tyrosine phosphoprotein. Wong S, Reynolds AB, Papkoff J (1992) Oncogene 7: 2407-15 Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation. Yamakawa Y, Takano M, Patel M, Tien N, Takada T, Bulkley GB (2000) Ann Surg 231: 387-98 Plasma membrane Ca(2+) -ATPase associates with CLP36, alpha-actinin and actin in human platelets. Bozulic LD, Malik MT, Powell DW, Nanez A, Link AJ, Ramos KS, Dean WL (2007) Thromb Haemost 97: 587-97 12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity. Yeung J, Apopa PL, Vesci J, Stolla M, Rai G, Simeonov A, Jadhav A, Fernandez-Perez P, Maloney DJ, Boutaud O, Holman TR, Holinstat M (2013) Thromb Haemost 110: 569-81 The alpha 2 beta 1 integrin: a collagen receptor on platelets and other cells. Santoro SA, Zutter MM (1995) Thromb Haemost 74: 813-21 Inherited human group IVA cytosolic phospholipase A2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation. Kirkby NS, Reed DM, Edin ML, Rauzi F, Mataragka S, Vojnovic I, Bishop-Bailey D, Milne GL, Longhurst H, Zeldin DC, Mitchell JA, Warner TD (2015) FASEB J 29: 4568-78 Quantification of diacylglycerol species from cellular extracts by electrospray ionization mass spectrometry using a linear regression algorithm. Callender HL, Forrester JS, Ivanova P, Preininger A, Milne S, Brown HA (2007) Anal Chem 79: 263-72 Activated platelets express IL-1 activity. Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER (1989) J Immunol 143: 4015-8 The effects of hemodialysis on platelet activation with new and reprocessed regenerated cellulose dialyzers. Windus DW, Atkinson R, Santoro S (1996) Am J Kidney Dis 27: 387-93 Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Despotis GJ, Levine V, Filos KS, Santoro SA, Joist JH, Spitznagel E, Goodnough LT (1996) Anesthesiology 85: 1311-23 Different preparations of zymosan induce glycogenolysis independently in the perfused rat liver. Involvement of mannose receptors, peptide-leukotrienes and prostaglandins. Kimura K, Shiota M, Mochizuki K, Ohta M, Sugano T (1992) Biochem J 283 ( Pt 3): 773-9 Levuglandinyl adducts of proteins are formed via a prostaglandin H2 synthase-dependent pathway after platelet activation. Boutaud O, Li J, Zagol I, Shipp EA, Davies SS, Roberts LJ, Oates JA (2003) J Biol Chem 278: 16926-8 PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation. Holinstat M, Voss B, Bilodeau ML, McLaughlin JN, Cleator J, Hamm HE (2006) J Biol Chem 281: 26665-74 Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. Marathe GK, Davies SS, Harrison KA, Silva AR, Murphy RC, Castro-Faria-Neto H, Prescott SM, Zimmerman GA, McIntyre TM (1999) J Biol Chem 274: 28395-404 Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. Zhu J, Xue J, Guo Z, Zhang L, Marchant RE (2007) Bioconjug Chem 18: 1366-9 Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice. Huttinger ZM, Milks MW, Nickoli MS, Aurand WL, Long LC, Wheeler DG, Dwyer KM, d'Apice AJ, Robson SC, Cowan PJ, Gumina RJ (2012) Am J Pathol 181: 322-33 Irreversible platelet activation requires protease-activated receptor 1-mediated signaling to phosphatidylinositol phosphates. Holinstat M, Preininger AM, Milne SB, Hudson WJ, Brown HA, Hamm HE (2009) Mol Pharmacol 76: 301-13 PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axis. Voss B, McLaughlin JN, Holinstat M, Zent R, Hamm HE (2007) Mol Pharmacol 71: 1399-406 Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation. Yeung J, Apopa PL, Vesci J, Kenyon V, Rai G, Jadhav A, Simeonov A, Holman TR, Maloney DJ, Boutaud O, Holinstat M (2012) Mol Pharmacol 81: 420-30 Protease-activated receptors differentially regulate human platelet activation through a phosphatidic acid-dependent pathway. Holinstat M, Voss B, Bilodeau ML, Hamm HE (2007) Mol Pharmacol 71: 686-94 Human platelets generate phospholipid-esterified prostaglandins via cyclooxygenase-1 that are inhibited by low dose aspirin supplementation. Aldrovandi M, Hammond VJ, Podmore H, Hornshaw M, Clark SR, Marnett LJ, Slatter DA, Murphy RC, Collins PW, O'Donnell VB (2013) J Lipid Res 54: 3085-97 Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver. Marathe GK, Harrison KA, Roberts LJ, Morrow JD, Murphy RC, Tjoelker LW, Prescott SM, Zimmerman GA, McIntyre TM (2001) J Lipid Res 42: 587-96 Shear-induced platelet activation measured by flow cytometry. Purvis NB, Giorgio TD, Stelzer GT, Shults KE (1994) Ann N Y Acad Sci 714: 309-11 Platelets in suspension require preactivation to adhere to immobilized fibrinogen. Bonnefoy A, Liu Q, Jerome WG, Legrand C, Frojmovic MM (2001) Ann N Y Acad Sci 936: 459-63 Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions. Bilodeau ML, Hamm HE (2007) J Pharmacol Exp Ther 322: 778-88 Synthesis of indole derived protease-activated receptor 4 antagonists and characterization in human platelets. Young SE, Duvernay MT, Schulte ML, Lindsley CW, Hamm HE (2013) PLoS One 8: e65528 α2β1 integrin, GPVI receptor, and common FcRγ chain on mouse platelets mediate distinct responses to collagen in models of thrombosis. Marjoram RJ, Li Z, He L, Tollefsen DM, Kunicki TJ, Dickeson SK, Santoro SA, Zutter MM (2014) PLoS One 9: e114035 Multiple episodes of thrombosis with biventricular support devices with inadequate anticoagulation and evidence of accelerated intravascular coagulation. Despotis GJ, Levine V, Joist H, Santoro SA, Mendeloff E (1997) J Thorac Cardiovasc Surg 113: 419-22 Inflammatory cytokine TSLP stimulates platelet secretion and potentiates platelet aggregation via a TSLPR-dependent PI3K/Akt signaling pathway. Dong J, Dong J, Lin J, Wang B, He S, Wu C, Kushwaha KK, Mohabeer N, Su Y, Fang H, Huang K, Li D (2015) Cell Physiol Biochem 35: 160-74 Platelet Lipidomic Profiling: Novel Insight into Cytosolic Phospholipase A2α Activity and Its Role in Human Platelet Activation. Duvernay MT, Matafonov A, Lindsley CW, Hamm HE (2015) Biochemistry 54: 5578-88 Effects of platelets and white blood cells and antiplatelet agent C7E3 (Reopro) on a new test of PAF procoagulant activity of whole blood. Despotis GJ, Ikonomakou S, Levine V, Joiner-Maier D, Santoro SA, Joist JH (1997) Thromb Res 86: 205-19 Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo. Kimura K, Moriyama M, Nishisako M, Kannan Y, Shiota M, Sakurada K, Musashi M, Sugano T (1998) J Biochem 123: 142-9 Hemocompatibility of silicon-based substrates for biomedical implant applications. Muthusubramaniam L, Lowe R, Fissell WH, Li L, Marchant RE, Desai TA, Roy S (2011) Ann Biomed Eng 39: 1296-305
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.